EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ACVIM consensus statement on the diagnosis of immune thrombocytopenia in dogs and cats

Dana N LeVine iD, Linda Kidd iD, Oliver A Garden iD, Marjory B Brooks iD, Robert Goggs iD, Barbara Kohn, Andrew J Mackin iD, Erin R B Eldermire, Yu-Mei Chang iD, Julie Allen, Peter W Christopherson, Barbara Glanemann iD und 14 weitere

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.16996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Dana N LeVine und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA. Hauptthemen laut MEDLINE: Cat Diseases, Dog Diseases, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 192 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune thrombocytopenia (ITP) is the most common acquired primary hemostatic disorder in dogs. Immune thrombocytopenia less commonly affects cats but is an important cause of mortality and treatment-associated morbidity in both species. Immune thrombocytopenia remains a diagnosis of exclusion for which diagnostic guidelines are lacking. Primary, or non-associative, ITP refers to autoimmune platelet destruction. Secondary, or associative, ITP arises in response to an underlying disease trigger. However, evidence for which comorbidities serve as ITP triggers has not been systematically evaluated. To identify key diagnostic steps for ITP and important comorbidities associated with secondary ITP, we developed 12 Population Evaluation/Exposure Comparison Outcome (PECO) format questions. These questions were addressed by evidence evaluators utilizing a literature pool of 287 articles identified by the panelists using a structured search strategy. Evidence evaluators, using panel-designed templates and data extraction tools, summarized evidence and created guideline recommendations that then were integrated by diagnosis and comorbidity domain chairs. The revised PECO responses underwent a Delphi survey process to reach consensus on final guidelines. A combination of panel expertise and PECO responses were employed to develop algorithms for diagnosis of ITP in dogs and cats, which also underwent 4 iterations of Delphi review. Comorbidity evidence evaluators employed an integrated measure of evidence (IME) tool to determine evidence quality for each comorbidity; IME values combined with evidence summaries for each comorbidity were integrated to develop ITP screening recommendations, which also were subjected to Delphi review. Commentary was solicited from multiple relevant professional organizations before finalizing the consensus. The final consensus statement provides clinical guidelines for the diagnosis of, and underlying disease screening for, ITP in dogs and cats. The systematic consensus process identified numerous knowledge gaps that should guide future studies. This statement is a companion manuscript to the ACVIM Consensus Statement on the Treatment of Immune Thrombocytopenia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cat DiseasesDog DiseasesPurpura, Thrombocytopenic, IdiopathicAnimalsCatsDogs

Stichwörter der Autor:innen

autoimmunehemostasisimmune‐mediatedplateletthrombopoietin

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, Auburn University, Auburn, Alabama, USA.
  • Western University of Health Sciences College of Veterinary Medicine, Pomona, California, USA.
  • Zoetis Animal Health Diagnostics, Parsippany, New Jersey, USA.
  • School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana, USA.
  • Department of Population Medicine and Diagnostic Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.
  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, USA.

ORCID-Profile: Dana N LeVine, Linda Kidd, Oliver A Garden, Marjory B Brooks, Robert Goggs, Andrew J Mackin, Yu-Mei Chang, Barbara Glanemann, Maria C Naskou, Lise N Nielsen, Adam J Birkenheuer, Andrew S Hanzlicek, Kathrin F Langner, Erin Lashnits, Katharine F Lunn, Kelly M Makielski, Eva Spada

Förderung

  • NCATS NIH HHS

Zitieren

APA

LeVine, D. N., Kidd, L., Garden, O. A., Brooks, M. B., Goggs, R., Kohn, B., Mackin, A. J., Eldermire, E. R. B., Chang, Y. M., Allen, J., Christopherson, P. W., Glanemann, B., Maruyama, H., Naskou, M. C., Nielsen, L. N., Shropshire, S., Viall, A. K., Birkenheuer, A. J., Forman, M. A., …, & Spada, E. (2024). ACVIM consensus statement on the diagnosis of immune thrombocytopenia in dogs and cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16996

Vancouver

LeVine DN, Kidd L, Garden OA, Brooks MB, Goggs R, Kohn B, et al. ACVIM consensus statement on the diagnosis of immune thrombocytopenia in dogs and cats. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.16996

BibTeX
@article{LeVine2024,
  author = {LeVine, Dana N and Kidd, Linda and Garden, Oliver A and Brooks, Marjory B and Goggs, Robert and Kohn, Barbara and Mackin, Andrew J and Eldermire, Erin R B and Chang, Yu-Mei and Allen, Julie and Christopherson, Peter W and Glanemann, Barbara and Maruyama, Haruhiko and Naskou, Maria C and Nielsen, Lise N and Shropshire, Sarah and Viall, Austin K and Birkenheuer, Adam J and Forman, Marnin A and Hanzlicek, Andrew S and Langner, Kathrin F and Lashnits, Erin and Lunn, Katharine F and Makielski, Kelly M and Roura, Xavier and Spada, Eva},
  title = {ACVIM consensus statement on the diagnosis of immune thrombocytopenia in dogs and cats},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.16996}
}
Kostenlos starten →